Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK1070806 in Behcet's Disease
NCT03522662Phase 2Unknown
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Aug 2018
- Primary completion
- Apr 2020
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of aletekitug in Behcet's disease (BD), sponsored by Cambridge University Hospitals NHS Foundation Trust. Status: unknown.
02
Drugs
aletekitug
03
Conditions
Behcet's disease (BD)
Beyond the preview
Go deeper on NCT03522662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03522662.